(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.01%) $79.01
(5.02%) $2.03
(0.03%) $2 311.60
(0.56%) $26.90
(0.72%) $961.80
(-0.07%) $0.932
(-0.45%) $10.98
(-0.09%) $0.798
(-1.35%) $92.00
@ $12.30
Issued: 11 Apr 2024 @ 12:30
Return: -30.08%
Previous signal: Apr 11 - 10:25
Previous signal:
Return: -0.89 %
Live Chart Being Loaded With Signals
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis...
Stats | |
---|---|
Today's Volume | 1.69M |
Average Volume | 3.91M |
Market Cap | 988.75M |
EPS | $0 ( 2024-02-27 ) |
Next earnings date | ( $-0.600 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.28 |
ATR14 | $0.0130 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Topper David Joseph | Buy | 310 000 | Stock Option (right to buy) |
2024-04-10 | Topper David Joseph | Buy | 110 000 | Common Stock |
2024-04-10 | Topper David Joseph | Sell | 7 500 | Stock Option (right to buy) |
2024-03-04 | Matsuda Masaru | Sell | 3 760 | Common Stock |
2024-03-04 | Burnett Patrick | Sell | 4 782 | Common Stock |
INSIDER POWER |
---|
30.74 |
Last 98 transactions |
Buy: 3 267 821 | Sell: 1 662 580 |
Volume Correlation
Arcutis Biotherapeutics Correlation
10 Most Positive Correlations | |
---|---|
RCKY | 0.919 |
MORN | 0.915 |
WBA | 0.911 |
CPTN | 0.907 |
CSSE | 0.905 |
PENN | 0.903 |
CNSL | 0.902 |
ENNV | 0.901 |
CSTE | 0.898 |
NYMT | 0.897 |
10 Most Negative Correlations | |
---|---|
OBT | -0.916 |
PRGS | -0.915 |
HTBI | -0.914 |
NWPX | -0.911 |
KTCC | -0.909 |
VC | -0.907 |
HUBG | -0.897 |
JBSS | -0.889 |
WSC | -0.889 |
PRN | -0.886 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Arcutis Biotherapeutics Correlation - Currency/Commodity
Arcutis Biotherapeutics Financials
Annual | 2023 |
Revenue: | $59.61M |
Gross Profit: | $53.49M (89.74 %) |
EPS: | $-3.78 |
FY | 2023 |
Revenue: | $59.61M |
Gross Profit: | $53.49M (89.74 %) |
EPS: | $-3.78 |
FY | 2022 |
Revenue: | $3.69M |
Gross Profit: | $2.93M (79.54 %) |
EPS: | $-5.84 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-5.79 |
Financial Reports:
No articles found.
Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators